PrescriberPoint - Assistance Fund: Immunoglobulin A Nephropathy (IgAN)

This program provides financial assistance to eligible residents of the US and Puerto Rico who are prescribed Tarpeyo, Filspari, or Fabhalta for Immunoglobulin A Nephropathy (IgAN). It covers copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses, and requires patients to be commercially insured or have Medicare/Medicaid and meet income guidelines.